Clinical Trial Update: MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301

View source ↗

Summary

Extension study update for patients with non-infectious uveitis who participated in CLS1001-301 (MAGNOLIA) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-infectious Uveitis
• Panuveitis
• Uveitis Anterior
• Uveitis Intermediate
• Uveitis Posterior

Snippet

Sponsor: Clearside Biomedical, Inc. | Conditions: Uveitis, Uveitis, Posterior | Status: COMPLETED | Results posted: 2021-05-07